Thomas W. Stone, MD
Dartmouth College, Magna Cum Laude
Medical School MD:
University of Buffalo, Summa Cum Laude
Duke University Eye Center, Chief Resident
Emory University Eye Center, Vitreoretinal Disease
Honors and Associations
Best Doctors in America
America’s Top Ophthalmologists
American Society of Retinal Specialists – Fellow, 2002 – present
American Academy of Ophthalmology – Fellow, 2000 – present
Editor, Preferences and Trends Survey, 2013 – present
Louisville Academy of Ophthalmology, 2013 – present
Lexington Academy of Eye Physicians and Surgeons, 2002 – present
Kentucky Academy of Eye Physicians and Surgeons
Diabetic Retinopathy Clinical Research Network – Diabetic Eye Disease – Principal Investigator
Boulevard Trial – Diabetic Eye Disease – Investigator
Panorama Trial – Diabetic Eye Disease – Investigator
LADDER Trial – Macular Degeneration – Investigator
TOGA Trial – Macular Degeneration – Investigator
SCORE2 Trial – Vein Occlusion – Investigator
BRAVO Trial – Vein Occlusion – Investigator
CRUISE Trial – Vein Occlusion – Investigator
CATT Trial – Macular Degeneration – Principal Investigator
AREDS 2 Trial – Macular Degeneration – Investigator
PRELUDE Trial – Macular Degeneration – Investigator
ROLL Trial – Macular Degeneration – Investigator
Harbor Trial – Macular Degeneration – Investigator
Denali Trial – Macular Degeneration – Investigator
Handle Trial – Ocular Histoplasmosis – Investigator
LOHS Trial – Ocular Histoplasmosis – Investigator
Meet Thomas W. Stone, MD – Eye to Eye Video Interviews
What led you to choose Retina Associates?
When I was completing my fellowship at Emory University, I already knew I wanted to be in an established retina practice with nationally recognized colleagues. It came down to several leading academic institutions and Retina Associates of Kentucky. The moment I met Drs. Wood and Isernhagen and the staff here, I knew that this was the place I wanted to be. The opportunity to care for patients and pursue research was very apparent, and I’ve been happy over the years to be a part of this practice. Over the last four years, the retinal care needs in our state has increased dramatically. I’ve been proud to be part of a practice where we can add four new doctors, each with tremendous ability to care for patients, to help meet this need.
What are your interests?
I have a fairly broad range of professional interests that include macular degeneration and diabetes, the two most common conditions we treat. While we have ways of treating both of these diseases, the best way to treat each patient is becoming more complicated as we have more than one treatment. Each patient is unique, and to decide which treatment will help them see and function better is a constant challenge that I pursue daily.
At the same time we are striving to improve the patient experience with surgical cases such as floaters, macular hole, epiretinal membrane and vitreous hemorrhage. The surgery time, recovery time, and patient discomfort associated with these conditions have been greatly reduced over the past several years, and I am interested in furthering this improvement in patient care.
I also enjoy collaborating with other physicians besides the retina specialist on a few less common conditions such as uveitis which can be challenging for the patient and the doctor.
Over the last few years, we have also been refining our ability to improve the quality of life and vision in patients with disabling floaters. These patients have often been suffering from this condition for years, and can be frustrated with the prior lack of effective treatment. Our surgical techniques are now making this a treatable condition in some select patients where the benefit outweighs the risk.
What research are you working on?
I am currently working on several projects. For over ten years, we’ve been working with the National Eye Institute in Washington, DC to determine the best way to treat all types of diabetic retinopathy. We’ve had over 100 patients enrolled in a variety of clinical trials over that time, and have learned a lot about how to care for these patients. Over the past few years we have also been investigating the best way to treat patients with ocular histoplasmosis and have published some of the most comprehensive studies on this condition, as it is found primarily in this part of the country. We also have an ongoing interest in macular degeneration, both wet and dry forms, as it is a common condition that affects many of our patients.
What do you enjoy outside of medicine?
I enjoy spending time with my family. We spend a lot of time outside walking and biking in our neighborhood of Anchorage. We have a lake house, and like to spend some time there boating and fishing. I also enjoy fine food, photography, new technology, and discovering new places to travel with my family.